The Generic Drug Trilemma

Article Properties
Cite
Hemel, Daniel J., and Lisa Larrimore Ouellette. “The Generic Drug Trilemma”. Entrepreneurship and Innovation Policy and the Economy, vol. 2, 2023, pp. 41-77, https://doi.org/10.1086/723235.
Hemel, D. J., & Ouellette, L. L. (2023). The Generic Drug Trilemma. Entrepreneurship and Innovation Policy and the Economy, 2, 41-77. https://doi.org/10.1086/723235
Hemel DJ, Ouellette LL. The Generic Drug Trilemma. Entrepreneurship and Innovation Policy and the Economy. 2023;2:41-77.
Refrences
Title Journal Journal Categories Citations Publication Date
2021 FDA approvals Nature Reviews Drug Discovery
  • Technology: Chemical technology: Biotechnology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
71 2022
Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021 JAMA Health Forum
  • Medicine: Public aspects of medicine
  • Medicine: Medicine (General): Medical technology
  • Medicine: Public aspects of medicine
  • Medicine: Internal medicine: Special situations and conditions: Industrial medicine. Industrial hygiene
4 2022
Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions JAMA Internal Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
  • Medicine: Medicine (General)
22 2021
10.37419/JPL.V7.I1.3 2021
Bureaucratic Competence and Procurement Outcomes

The Journal of Law, Economics, and Organization
  • Social Sciences: Commerce: Business
  • Social Sciences: Economic theory. Demography: Economics as a science
  • Law
  • Social Sciences: Commerce: Business
  • Social Sciences: Economic theory. Demography: Economics as a science
27 2020